{"product_id":"bromantane-1g","title":"Bromantane 1g","description":"\u003cp data-start=\"384\" data-end=\"774\" class=\"\"\u003e\u003cstrong data-start=\"384\" data-end=\"398\"\u003e\u003cstrong data-end=\"392\" data-start=\"377\"\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e\u003cstrong\u003e                                           \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003eFOR HUMAN CONSUMPTION\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"384\" data-end=\"774\" class=\"\"\u003e\u003cstrong data-start=\"384\" data-end=\"398\"\u003e\u003cstrong data-end=\"392\" data-start=\"377\"\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003e\u003cstrong\u003e\u003cmeta charset=\"UTF-8\"\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003c\/strong\u003e\u003cstrong\u003eBromantane\u003c\/strong\u003e is an \u003cstrong data-end=\"141\" data-start=\"105\"\u003eadamantane-derived actoprotector\u003c\/strong\u003e developed in Russia and marketed there as \u003cstrong data-end=\"197\" data-start=\"184\"\u003eLadasten®\u003c\/strong\u003e for \u003cstrong data-end=\"223\" data-start=\"202\"\u003easthenic syndrome\u003c\/strong\u003e. Pharmacologically it behaves as a \u003cstrong data-end=\"307\" data-start=\"259\"\u003epro-dopaminergic, anxiolytic psychostimulant\u003c\/strong\u003e with \u003cstrong data-end=\"328\" data-start=\"313\"\u003eadaptogenic\u003c\/strong\u003e and \u003cstrong data-end=\"353\" data-start=\"333\"\u003eimmunomodulatory\u003c\/strong\u003e signals. Unlike classic stimulants, it \u003cstrong data-end=\"433\" data-start=\"393\"\u003eup-regulates catecholamine synthesis\u003c\/strong\u003e(rather than driving acute release), with reported increases in \u003cstrong data-end=\"527\" data-start=\"498\"\u003etyrosine hydroxylase (TH)\u003c\/strong\u003e and \u003cstrong data-end=\"578\" data-start=\"532\"\u003earomatic L-amino acid decarboxylase (AADC)\u003c\/strong\u003e expression, plus mild \u003cstrong data-end=\"614\" data-start=\"601\"\u003eGABAergic\u003c\/strong\u003e and \u003cstrong data-end=\"635\" data-start=\"619\"\u003eserotonergic\u003c\/strong\u003e modulation. It is \u003cstrong data-end=\"670\" data-start=\"654\"\u003enot approved\u003c\/strong\u003e in the US\/EU and is \u003cstrong data-end=\"714\" data-start=\"691\"\u003eprohibited in sport\u003c\/strong\u003e (stimulants class).\u003c\/p\u003e\n\u003chr data-end=\"739\" data-start=\"736\"\u003e\n\u003ch3 data-end=\"802\" data-start=\"741\"\u003eAdditional Benefits of Bromantane Now Under Investigation\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"3229\" data-start=\"804\"\u003e\n\u003cthead data-end=\"832\" data-start=\"804\"\u003e\n\u003ctr data-end=\"832\" data-start=\"804\"\u003e\n\u003cth data-col-size=\"md\" data-end=\"814\" data-start=\"804\"\u003eBenefit\u003c\/th\u003e\n\u003cth data-col-size=\"xl\" data-end=\"832\" data-start=\"814\"\u003eKey take-aways\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"3229\" data-start=\"843\"\u003e\n\u003ctr data-end=\"1173\" data-start=\"843\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"891\" data-start=\"843\"\u003e\u003cstrong data-end=\"890\" data-start=\"845\"\u003e1 Anti-fatigue \u0026amp; performance under stress\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"1173\" data-start=\"891\"\u003eIn asthenia and military\/occupational studies, bromantane improved \u003cstrong data-end=\"973\" data-start=\"960\"\u003evigilance\u003c\/strong\u003e, \u003cstrong data-end=\"996\" data-start=\"975\"\u003epsychomotor speed\u003c\/strong\u003e, and \u003cstrong data-end=\"1018\" data-start=\"1002\"\u003etime-on-task\u003c\/strong\u003e during heat, sleep restriction, or high workload—without classic stimulant rebound. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Human Physiology; Neuroscience \u0026amp; Behavioral Physiology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1456\" data-start=\"1174\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1209\" data-start=\"1174\"\u003e\u003cstrong data-end=\"1208\" data-start=\"1176\"\u003e2 Anxiolysis with activation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1456\" data-start=\"1209\" data-col-size=\"xl\"\u003eClinical cohorts with neurasthenia\/asthenic anxiety report \u003cstrong data-end=\"1320\" data-start=\"1270\"\u003ereduced anxiety, apathy, and asthenic symptoms\u003c\/strong\u003e while \u003cstrong data-end=\"1352\" data-start=\"1327\"\u003eenergy and initiative\u003c\/strong\u003e rise—an uncommon “calm activation” profile. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Zhurnal Nevrologii i Psikhiatrii; CNS Drugs\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1719\" data-start=\"1457\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1486\" data-start=\"1457\"\u003e\u003cstrong data-end=\"1485\" data-start=\"1459\"\u003e3 Cognitive efficiency\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1719\" data-start=\"1486\" data-col-size=\"xl\"\u003eSignals for \u003cstrong data-end=\"1518\" data-start=\"1500\"\u003eworking memory\u003c\/strong\u003e, \u003cstrong data-end=\"1540\" data-start=\"1520\"\u003eprocessing speed\u003c\/strong\u003e, and \u003cstrong data-end=\"1559\" data-start=\"1546\"\u003eattention\u003c\/strong\u003e improvements in fatigued subjects; effects in healthy, rested volunteers are smaller and variable. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Human Psychopharmacology; Psychopharmacology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"1964\" data-start=\"1720\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1754\" data-start=\"1720\"\u003e\u003cstrong data-end=\"1753\" data-start=\"1722\"\u003e4 Recovery and overtraining\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"1964\" data-start=\"1754\" data-col-size=\"xl\"\u003eActoprotector literature notes \u003cstrong data-end=\"1806\" data-start=\"1787\"\u003efaster recovery\u003c\/strong\u003e of heart-rate variability and \u003cstrong data-end=\"1865\" data-start=\"1837\"\u003elower perceived exertion\u003c\/strong\u003e post-load; high-quality athlete RCTs are sparse. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Sports Medicine; Human Physiology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2242\" data-start=\"1965\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"1990\" data-start=\"1965\"\u003e\u003cstrong data-end=\"1989\" data-start=\"1967\"\u003e5 Immunomodulation\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2242\" data-start=\"1990\"\u003eReports of \u003cstrong data-end=\"2035\" data-start=\"2003\"\u003eenhanced interferon response\u003c\/strong\u003e, \u003cstrong data-end=\"2056\" data-start=\"2037\"\u003e↑ secretory IgA\u003c\/strong\u003e, and \u003cstrong data-end=\"2079\" data-start=\"2062\"\u003e↑ NK activity\u003c\/strong\u003e in stressed individuals—magnitude and durability remain uncertain. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;International Immunopharmacology; Bulletin of Experimental Biology and Medicine\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2485\" data-start=\"2243\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2291\" data-start=\"2243\"\u003e\u003cstrong data-end=\"2290\" data-start=\"2245\"\u003e6 Antihypoxic\/thermoregulatory resilience\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2485\" data-start=\"2291\" data-col-size=\"xl\"\u003eAnimal data show protection against \u003cstrong data-end=\"2342\" data-start=\"2329\"\u003eheat load\u003c\/strong\u003e and \u003cstrong data-end=\"2358\" data-start=\"2347\"\u003ehypoxia\u003c\/strong\u003e with better mitochondrial enzyme activity and oxidative-stress markers. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Pathophysiology; Biochemistry (Moscow)\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2751\" data-start=\"2486\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2531\" data-start=\"2486\"\u003e\u003cstrong data-end=\"2530\" data-start=\"2488\"\u003e7 Mood\/drive in post-infection fatigue\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"2751\" data-start=\"2531\" data-col-size=\"xl\"\u003eSmall open studies suggest \u003cstrong data-end=\"2605\" data-start=\"2560\"\u003eimproved motivation and physical activity\u003c\/strong\u003e in post-viral asthenia; controlled trials needed. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Clinical Pharmacology \u0026amp; Therapeutics (regional); Journal of Affective Disorders\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"2982\" data-start=\"2752\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"2784\" data-start=\"2752\"\u003e\u003cstrong data-end=\"2783\" data-start=\"2754\"\u003e8 Autonomic stabilization\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-end=\"2982\" data-start=\"2784\"\u003eTrends toward \u003cstrong data-end=\"2831\" data-start=\"2800\"\u003elower sympathetic overdrive\u003c\/strong\u003e at rest with more robust \u003cstrong data-end=\"2881\" data-start=\"2857\"\u003etask-evoked response\u003c\/strong\u003e, consistent with central set-point effects. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Autonomic Neuroscience; Psychophysiology\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"3229\" data-start=\"2983\"\u003e\n\u003ctd data-col-size=\"md\" data-end=\"3022\" data-start=\"2983\"\u003e\u003cstrong data-end=\"3021\" data-start=\"2985\"\u003e9 Low abuse potential (relative)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3229\" data-start=\"3022\" data-col-size=\"xl\"\u003eLacks strong euphoria\/reinforcement typical of amphetamines; discontinuation symptoms uncommon—though misuse in sport led to \u003cstrong data-end=\"3169\" data-start=\"3149\"\u003eWADA prohibition\u003c\/strong\u003e. \u0026lt;br\/\u0026gt;\u0026lt;em\u0026gt;Addiction Biology; Drug Testing \u0026amp; Analysis\u0026lt;\/em\u0026gt;\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"3234\" data-start=\"3231\"\u003e\n\u003ch2 data-end=\"3271\" data-start=\"3236\"\u003e2. Molecular Mechanism of Action\u003c\/h2\u003e\n\u003ch3 data-end=\"3318\" data-start=\"3273\"\u003e2.1 Receptor\/enzymatic pharmacodynamics\u003c\/h3\u003e\n\u003cul data-end=\"3826\" data-start=\"3319\"\u003e\n\u003cli data-end=\"3555\" data-start=\"3319\"\u003e\n\u003cp data-end=\"3555\" data-start=\"3321\"\u003e\u003cstrong data-end=\"3338\" data-start=\"3321\"\u003eDopaminergic:\u003c\/strong\u003e Up-regulates \u003cstrong data-end=\"3358\" data-start=\"3352\"\u003eTH\u003c\/strong\u003e (rate-limiting for DA) and \u003cstrong data-end=\"3394\" data-start=\"3386\"\u003eAADC\u003c\/strong\u003e, increasing \u003cstrong data-end=\"3437\" data-start=\"3407\"\u003ede novo dopamine synthesis\u003c\/strong\u003e and \u003cstrong data-end=\"3473\" data-start=\"3442\"\u003emesolimbic\/striatal DA tone\u003c\/strong\u003e without vesicular dump; may elevate \u003cstrong data-end=\"3518\" data-start=\"3510\"\u003eBDNF\u003c\/strong\u003e transcripts in cortex\/hippocampus.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3688\" data-start=\"3556\"\u003e\n\u003cp data-end=\"3688\" data-start=\"3558\"\u003e\u003cstrong data-end=\"3583\" data-start=\"3558\"\u003eGABA\/5-HT modulation:\u003c\/strong\u003e Mild \u003cstrong data-end=\"3617\" data-start=\"3589\"\u003eGABA-ergic normalization\u003c\/strong\u003e and \u003cstrong data-end=\"3639\" data-start=\"3622\"\u003e5-HT turnover\u003c\/strong\u003e changes reported (contributing to anxiolysis).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3826\" data-start=\"3689\"\u003e\n\u003cp data-end=\"3826\" data-start=\"3691\"\u003e\u003cstrong data-end=\"3723\" data-start=\"3691\"\u003eMitochondrial\/actoprotector:\u003c\/strong\u003e ↑ activity of \u003cstrong data-end=\"3765\" data-start=\"3738\"\u003esuccinate dehydrogenase\u003c\/strong\u003e, \u003cstrong data-end=\"3789\" data-start=\"3767\"\u003ecytochrome oxidase\u003c\/strong\u003e, and antioxidant systems under load.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-end=\"3855\" data-start=\"3828\"\u003e2.2 Down-stream biology\u003c\/h3\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"4240\" data-start=\"3857\"\u003e\n\u003cthead data-end=\"3899\" data-start=\"3857\"\u003e\n\u003ctr data-end=\"3899\" data-start=\"3857\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3867\" data-start=\"3857\"\u003ePathway\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3888\" data-start=\"3867\"\u003eFunctional outcome\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"3899\" data-start=\"3888\"\u003eContext\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"4240\" data-start=\"3914\"\u003e\n\u003ctr data-end=\"4000\" data-start=\"3914\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"3945\" data-start=\"3914\"\u003e\u003cstrong data-end=\"3944\" data-start=\"3916\"\u003eTH\/AADC induction → DA ↑\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"3977\" data-start=\"3945\" data-col-size=\"sm\"\u003eDrive\/motivation ↑, fatigue ↓\u003c\/td\u003e\n\u003ctd data-end=\"4000\" data-start=\"3977\" data-col-size=\"sm\"\u003eStriatum\/mesolimbic\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4075\" data-start=\"4001\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4026\" data-start=\"4001\"\u003e\u003cstrong data-end=\"4025\" data-start=\"4003\"\u003eGABA normalization\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"4056\" data-start=\"4026\" data-col-size=\"sm\"\u003eAnxiety ↓, smoother arousal\u003c\/td\u003e\n\u003ctd data-end=\"4075\" data-start=\"4056\" data-col-size=\"sm\"\u003eLimbic\/cortical\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4163\" data-start=\"4076\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4117\" data-start=\"4076\"\u003e\u003cstrong data-end=\"4116\" data-start=\"4078\"\u003eMitochondrial enzymes\/antioxidants\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"4149\" data-start=\"4117\" data-col-size=\"sm\"\u003eStress resilience, recovery ↑\u003c\/td\u003e\n\u003ctd data-end=\"4163\" data-start=\"4149\" data-col-size=\"sm\"\u003eMuscle\/CNS\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"4240\" data-start=\"4164\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"4199\" data-start=\"4164\"\u003e\u003cstrong data-end=\"4198\" data-start=\"4166\"\u003eImmune signaling (IFN, sIgA)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"4228\" data-start=\"4199\" data-col-size=\"sm\"\u003eMucosal defense ↑ (stress)\u003c\/td\u003e\n\u003ctd data-end=\"4240\" data-start=\"4228\" data-col-size=\"sm\"\u003eImmunity\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"4245\" data-start=\"4242\"\u003e\n\u003ch2 data-end=\"4269\" data-start=\"4247\"\u003e3. Pharmacokinetics\u003c\/h2\u003e\n\u003cul data-end=\"4710\" data-start=\"4271\"\u003e\n\u003cli data-end=\"4312\" data-start=\"4271\"\u003e\n\u003cp data-end=\"4312\" data-start=\"4273\"\u003e\u003cstrong data-end=\"4283\" data-start=\"4273\"\u003eRoute:\u003c\/strong\u003e \u003cstrong data-end=\"4292\" data-start=\"4284\"\u003eOral\u003c\/strong\u003e tablets\/capsules.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4412\" data-start=\"4313\"\u003e\n\u003cp data-end=\"4412\" data-start=\"4315\"\u003e\u003cstrong data-end=\"4325\" data-start=\"4315\"\u003eOnset:\u003c\/strong\u003e \u003cstrong data-end=\"4334\" data-start=\"4326\"\u003eDays\u003c\/strong\u003e for anxiolytic\/activation profile; anti-fatigue often within \u003cstrong data-end=\"4409\" data-start=\"4396\"\u003e1–2 weeks\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4558\" data-start=\"4413\"\u003e\n\u003cp data-end=\"4558\" data-start=\"4415\"\u003e\u003cstrong data-end=\"4429\" data-start=\"4415\"\u003eHalf-life:\u003c\/strong\u003e Reported in the \u003cstrong data-end=\"4468\" data-start=\"4446\"\u003ehours-to low teens\u003c\/strong\u003e (compound and metabolite-dependent); \u003cstrong data-end=\"4520\" data-start=\"4506\"\u003eonce-daily\u003c\/strong\u003e dosing typical in Russian practice.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"4710\" data-start=\"4559\"\u003e\n\u003cp data-end=\"4710\" data-start=\"4561\"\u003e\u003cstrong data-end=\"4576\" data-start=\"4561\"\u003eMetabolism:\u003c\/strong\u003e Hepatic (oxidation\/hydroxylation of adamantane\/phenyl moieties) with renal\/biliary excretion; minimal CYP interaction data published.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"4715\" data-start=\"4712\"\u003e\n\u003ch2 data-end=\"4753\" data-start=\"4717\"\u003e4. Clinical Evidence (high-level)\u003c\/h2\u003e\n\u003cul data-end=\"5312\" data-start=\"4755\"\u003e\n\u003cli data-end=\"4996\" data-start=\"4755\"\u003e\n\u003cp data-end=\"4996\" data-start=\"4757\"\u003e\u003cstrong data-end=\"4793\" data-start=\"4757\"\u003eAsthenic\/neurasthenic syndromes:\u003c\/strong\u003e Randomized and open-label Russian trials show \u003cstrong data-end=\"4880\" data-start=\"4840\"\u003eclinician-rated and patient-reported\u003c\/strong\u003e improvements vs baseline and some actives\/placebo on \u003cstrong data-end=\"4965\" data-start=\"4934\"\u003easthenia and anxiety scales\u003c\/strong\u003e, with \u003cstrong data-end=\"4993\" data-start=\"4972\"\u003egood tolerability\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5172\" data-start=\"4997\"\u003e\n\u003cp data-end=\"5172\" data-start=\"4999\"\u003e\u003cstrong data-end=\"5030\" data-start=\"4999\"\u003eOperational stress studies:\u003c\/strong\u003e Controlled field studies (military\/industrial) report \u003cstrong data-end=\"5128\" data-start=\"5085\"\u003ebetter vigilance and psychomotor output\u003c\/strong\u003e in heat\/sleep restriction vs comparators.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"5312\" data-start=\"5173\"\u003e\n\u003cp data-end=\"5312\" data-start=\"5175\"\u003e\u003cstrong data-end=\"5189\" data-start=\"5175\"\u003eCognition:\u003c\/strong\u003e Mixed results—benefit most evident under \u003cstrong data-end=\"5257\" data-start=\"5231\"\u003efatigue or stress load\u003c\/strong\u003e; limited effect in \u003cstrong data-end=\"5300\" data-start=\"5277\"\u003ewell-rested healthy\u003c\/strong\u003evolunteers.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cblockquote data-end=\"5533\" data-start=\"5314\"\u003e\n\u003cp data-end=\"5533\" data-start=\"5316\"\u003e\u003cstrong data-end=\"5342\" data-start=\"5316\"\u003eEvidence quality note:\u003c\/strong\u003e Many trials are \u003cstrong data-end=\"5371\" data-start=\"5359\"\u003eregional\u003c\/strong\u003e, with varying blinding\/reporting standards; replication in \u003cstrong data-end=\"5459\" data-start=\"5431\"\u003emulticenter, modern RCTs\u003c\/strong\u003e is limited. Extrapolation to unrelated conditions should be conservative.\u003c\/p\u003e\n\u003c\/blockquote\u003e\n\u003chr data-end=\"5538\" data-start=\"5535\"\u003e\n\u003ch2 data-end=\"5573\" data-start=\"5540\"\u003e5. Emerging Clinical Interests\u003c\/h2\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"6084\" data-start=\"5575\"\u003e\n\u003cthead data-end=\"5605\" data-start=\"5575\"\u003e\n\u003ctr data-end=\"5605\" data-start=\"5575\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5583\" data-start=\"5575\"\u003eField\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5595\" data-start=\"5583\"\u003eRationale\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"5605\" data-start=\"5595\"\u003eStatus\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"6084\" data-start=\"5620\"\u003e\n\u003ctr data-end=\"5719\" data-start=\"5620\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5661\" data-start=\"5620\"\u003e\u003cstrong data-end=\"5660\" data-start=\"5622\"\u003ePost-viral\/post-infectious fatigue\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5699\" data-start=\"5661\" data-col-size=\"sm\"\u003eDopamine\/mitochondrial + anxiolysis\u003c\/td\u003e\n\u003ctd data-end=\"5719\" data-start=\"5699\" data-col-size=\"sm\"\u003ePilot\/open-label\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5826\" data-start=\"5720\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5766\" data-start=\"5720\"\u003e\u003cstrong data-end=\"5765\" data-start=\"5722\"\u003eChronic fatigue syndromes (ME\/CFS-like)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5801\" data-start=\"5766\" data-col-size=\"sm\"\u003eCentral drive + stress tolerance\u003c\/td\u003e\n\u003ctd data-end=\"5826\" data-start=\"5801\" data-col-size=\"sm\"\u003eHypothesis-generating\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"5911\" data-start=\"5827\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5853\" data-start=\"5827\"\u003e\u003cstrong data-end=\"5852\" data-start=\"5829\"\u003eOccupational safety\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5883\" data-start=\"5853\" data-col-size=\"sm\"\u003eVigilance without agitation\u003c\/td\u003e\n\u003ctd data-end=\"5911\" data-start=\"5883\" data-col-size=\"sm\"\u003eSmall operational trials\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6001\" data-start=\"5912\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"5953\" data-start=\"5912\"\u003e\u003cstrong data-end=\"5952\" data-start=\"5914\"\u003eAdjunct in depression with fatigue\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"5986\" data-start=\"5953\" data-col-size=\"sm\"\u003eEnergy\/initiative augmentation\u003c\/td\u003e\n\u003ctd data-end=\"6001\" data-start=\"5986\" data-col-size=\"sm\"\u003eCase series\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"6084\" data-start=\"6002\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"6027\" data-start=\"6002\"\u003e\u003cstrong data-end=\"6026\" data-start=\"6004\"\u003eRehab\/overtraining\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"6051\" data-start=\"6027\" data-col-size=\"sm\"\u003eRecovery facilitation\u003c\/td\u003e\n\u003ctd data-end=\"6084\" data-start=\"6051\" data-col-size=\"sm\"\u003eSports science (limited RCTs)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"6089\" data-start=\"6086\"\u003e\n\u003ch2 data-end=\"6120\" data-start=\"6091\"\u003e6. Safety and Tolerability\u003c\/h2\u003e\n\u003cul data-end=\"7117\" data-start=\"6122\"\u003e\n\u003cli data-end=\"6319\" data-start=\"6122\"\u003e\n\u003cp data-end=\"6319\" data-start=\"6124\"\u003e\u003cstrong data-end=\"6150\" data-start=\"6124\"\u003eCommon (usually mild):\u003c\/strong\u003e \u003cstrong data-end=\"6164\" data-start=\"6151\"\u003eDry mouth\u003c\/strong\u003e, \u003cstrong data-end=\"6192\" data-start=\"6166\"\u003einsomnia (early weeks)\u003c\/strong\u003e, \u003cstrong data-end=\"6206\" data-start=\"6194\"\u003eheadache\u003c\/strong\u003e, \u003cstrong data-end=\"6218\" data-start=\"6208\"\u003enausea\u003c\/strong\u003e, \u003cstrong data-end=\"6236\" data-start=\"6220\"\u003erestlessness\u003c\/strong\u003e, \u003cstrong data-end=\"6250\" data-start=\"6238\"\u003esweating\u003c\/strong\u003e; often resolve with dose-timing (morning) or brief dose reduction.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6433\" data-start=\"6320\"\u003e\n\u003cp data-end=\"6433\" data-start=\"6322\"\u003e\u003cstrong data-end=\"6338\" data-start=\"6322\"\u003eLess common:\u003c\/strong\u003e \u003cstrong data-end=\"6354\" data-start=\"6339\"\u003eTachycardia\u003c\/strong\u003e, \u003cstrong data-end=\"6368\" data-start=\"6356\"\u003eBP drift\u003c\/strong\u003e, \u003cstrong data-end=\"6380\" data-start=\"6370\"\u003etremor\u003c\/strong\u003e, \u003cstrong data-end=\"6398\" data-start=\"6382\"\u003eirritability\u003c\/strong\u003e; rare \u003cstrong data-end=\"6413\" data-start=\"6405\"\u003erash\u003c\/strong\u003e or \u003cstrong data-end=\"6430\" data-start=\"6417\"\u003edyspepsia\u003c\/strong\u003e.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6614\" data-start=\"6434\"\u003e\n\u003cp data-end=\"6614\" data-start=\"6436\"\u003e\u003cstrong data-end=\"6457\" data-start=\"6436\"\u003eNeuropsychiatric:\u003c\/strong\u003e Generally \u003cstrong data-end=\"6482\" data-start=\"6468\"\u003eanxiolytic\u003c\/strong\u003e, but activation can \u003cstrong data-end=\"6521\" data-start=\"6503\"\u003eunmask anxiety\u003c\/strong\u003e in some—monitor if panic-prone. \u003cstrong data-end=\"6573\" data-start=\"6554\"\u003eMania\/psychosis\u003c\/strong\u003e is rare; caution with bipolar history.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6708\" data-start=\"6615\"\u003e\n\u003cp data-end=\"6708\" data-start=\"6617\"\u003e\u003cstrong data-end=\"6643\" data-start=\"6617\"\u003eDependence\/withdrawal:\u003c\/strong\u003e Low relative to amphetamines; no classic rebound when tapered.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6822\" data-start=\"6709\"\u003e\n\u003cp data-end=\"6822\" data-start=\"6711\"\u003e\u003cstrong data-end=\"6729\" data-start=\"6711\"\u003eHepatic\/renal:\u003c\/strong\u003e Routine labs typically stable; avoid with \u003cstrong data-end=\"6803\" data-start=\"6772\"\u003esignificant hepatic disease\u003c\/strong\u003e until more data.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"6963\" data-start=\"6823\"\u003e\n\u003cp data-end=\"6963\" data-start=\"6825\"\u003e\u003cstrong data-end=\"6847\" data-start=\"6825\"\u003eDrug interactions:\u003c\/strong\u003e Limited data; be cautious with \u003cstrong data-end=\"6888\" data-start=\"6879\"\u003eMAOIs\u003c\/strong\u003e, strong \u003cstrong data-end=\"6914\" data-start=\"6897\"\u003edopaminergics\u003c\/strong\u003e, and \u003cstrong data-end=\"6938\" data-start=\"6920\"\u003eCNS stimulants\u003c\/strong\u003e (additive activation).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7017\" data-start=\"6964\"\u003e\n\u003cp data-end=\"7017\" data-start=\"6966\"\u003e\u003cstrong data-end=\"6990\" data-start=\"6966\"\u003ePregnancy\/lactation:\u003c\/strong\u003e Insufficient data—avoid.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7117\" data-start=\"7018\"\u003e\n\u003cp data-end=\"7117\" data-start=\"7020\"\u003e\u003cstrong data-end=\"7042\" data-start=\"7020\"\u003eSport\/anti-doping:\u003c\/strong\u003e \u003cstrong data-end=\"7061\" data-start=\"7043\"\u003eBanned by WADA\u003c\/strong\u003e (stimulants). Detection persists \u003cstrong data-end=\"7103\" data-start=\"7095\"\u003edays\u003c\/strong\u003e after dosing.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-end=\"7141\" data-start=\"7119\"\u003e\u003cstrong data-end=\"7141\" data-start=\"7119\"\u003eComparative matrix\u003c\/strong\u003e\u003c\/p\u003e\n\u003cdiv class=\"_tableContainer_1rjym_1\"\u003e\n\u003cdiv class=\"group _tableWrapper_1rjym_13 flex w-fit flex-col-reverse\" tabindex=\"-1\"\u003e\n\u003ctable class=\"w-fit min-w-(--thread-content-width)\" data-end=\"7528\" data-start=\"7143\"\u003e\n\u003cthead data-end=\"7209\" data-start=\"7143\"\u003e\n\u003ctr data-end=\"7209\" data-start=\"7143\"\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7153\" data-start=\"7143\"\u003eFeature\u003c\/th\u003e\n\u003cth data-col-size=\"md\" data-end=\"7170\" data-start=\"7153\"\u003e\u003cstrong data-end=\"7169\" data-start=\"7155\"\u003eBromantane\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7186\" data-start=\"7170\"\u003e\u003cstrong data-end=\"7185\" data-start=\"7172\"\u003eModafinil\u003c\/strong\u003e\u003c\/th\u003e\n\u003cth data-col-size=\"sm\" data-end=\"7209\" data-start=\"7186\"\u003e\u003cstrong data-end=\"7207\" data-start=\"7188\"\u003eMethylphenidate\u003c\/strong\u003e\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-end=\"7528\" data-start=\"7228\"\u003e\n\u003ctr data-end=\"7351\" data-start=\"7228\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7245\" data-start=\"7228\"\u003ePrimary action\u003c\/td\u003e\n\u003ctd data-end=\"7293\" data-start=\"7245\" data-col-size=\"md\"\u003e\n\u003cstrong data-end=\"7265\" data-start=\"7247\"\u003eDA synthesis ↑\u003c\/strong\u003e, actoprotector, anxiolytic\u003c\/td\u003e\n\u003ctd data-end=\"7327\" data-start=\"7293\" data-col-size=\"sm\"\u003eWake-promoter (DA\/NE transport)\u003c\/td\u003e\n\u003ctd data-end=\"7351\" data-start=\"7327\" data-col-size=\"sm\"\u003eDA\/NE reuptake block\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7400\" data-start=\"7352\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7362\" data-start=\"7352\"\u003eAnxiety\u003c\/td\u003e\n\u003ctd data-end=\"7372\" data-start=\"7362\" data-col-size=\"md\"\u003eOften ↓\u003c\/td\u003e\n\u003ctd data-end=\"7391\" data-start=\"7372\" data-col-size=\"sm\"\u003eNeutral\/slight ↑\u003c\/td\u003e\n\u003ctd data-end=\"7400\" data-start=\"7391\" data-col-size=\"sm\"\u003eCan ↑\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7452\" data-start=\"7401\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7419\" data-start=\"7401\"\u003eAbuse potential\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-end=\"7431\" data-start=\"7419\"\u003e\u003cstrong data-end=\"7430\" data-start=\"7421\"\u003eLower\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7442\" data-start=\"7431\"\u003eModerate\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7452\" data-start=\"7442\"\u003eHigher\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-end=\"7528\" data-start=\"7453\"\u003e\n\u003ctd data-col-size=\"sm\" data-end=\"7467\" data-start=\"7453\"\u003eWADA status\u003c\/td\u003e\n\u003ctd data-end=\"7484\" data-start=\"7467\" data-col-size=\"md\"\u003e\u003cstrong data-end=\"7483\" data-start=\"7469\"\u003eProhibited\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd data-end=\"7514\" data-start=\"7484\" data-col-size=\"sm\"\u003eProhibited (in-competition)\u003c\/td\u003e\n\u003ctd data-end=\"7528\" data-start=\"7514\" data-col-size=\"sm\"\u003eProhibited\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-end=\"7533\" data-start=\"7530\"\u003e\n\u003ch2 data-end=\"7561\" data-start=\"7535\"\u003e7. Regulatory Landscape\u003c\/h2\u003e\n\u003cul data-end=\"7809\" data-start=\"7563\"\u003e\n\u003cli data-end=\"7620\" data-start=\"7563\"\u003e\n\u003cp data-end=\"7620\" data-start=\"7565\"\u003e\u003cstrong data-end=\"7582\" data-start=\"7565\"\u003eApproved use:\u003c\/strong\u003e \u003cstrong data-end=\"7597\" data-start=\"7583\"\u003eRussia\/CIS\u003c\/strong\u003e (asthenic syndrome).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7716\" data-start=\"7621\"\u003e\n\u003cp data-end=\"7716\" data-start=\"7623\"\u003e\u003cstrong data-end=\"7633\" data-start=\"7623\"\u003eUS\/EU:\u003c\/strong\u003e Not approved; available only as \u003cstrong data-end=\"7694\" data-start=\"7666\"\u003eresearch chemical\/import\u003c\/strong\u003e (quality variable).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"7809\" data-start=\"7717\"\u003e\n\u003cp data-end=\"7809\" data-start=\"7719\"\u003e\u003cstrong data-end=\"7729\" data-start=\"7719\"\u003eSport:\u003c\/strong\u003e \u003cstrong data-end=\"7744\" data-start=\"7730\"\u003eProhibited\u003c\/strong\u003e substance (stimulants). High-profile positives drove early bans.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"7814\" data-start=\"7811\"\u003e\n\u003ch2 data-end=\"7858\" data-start=\"7816\"\u003e8. Practical Use \u0026amp; Dosing (where legal)\u003c\/h2\u003e\n\u003cul data-end=\"8399\" data-start=\"7860\"\u003e\n\u003cli data-end=\"8047\" data-start=\"7860\"\u003e\n\u003cp data-end=\"8047\" data-start=\"7862\"\u003e\u003cstrong data-end=\"7881\" data-start=\"7862\"\u003eTypical ranges:\u003c\/strong\u003e \u003cstrong data-end=\"7906\" data-start=\"7882\"\u003e50–100 mg once daily\u003c\/strong\u003e (morning) for \u003cstrong data-end=\"7934\" data-start=\"7921\"\u003e2–4 weeks\u003c\/strong\u003e, extend to \u003cstrong data-end=\"7960\" data-start=\"7946\"\u003e8–12 weeks\u003c\/strong\u003e if needed; some protocols use \u003cstrong data-end=\"8009\" data-start=\"7991\"\u003e100–200 mg\/day\u003c\/strong\u003e in divided doses under supervision.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8260\" data-start=\"8048\"\u003e\n\u003cp data-end=\"8260\" data-start=\"8050\"\u003e\u003cstrong data-end=\"8069\" data-start=\"8050\"\u003eTitration tips:\u003c\/strong\u003e Start \u003cstrong data-end=\"8089\" data-start=\"8076\"\u003e50 mg qAM\u003c\/strong\u003e, advance after \u003cstrong data-end=\"8117\" data-start=\"8105\"\u003e3–7 days\u003c\/strong\u003e if insomnia or jitteriness absent. Pair with \u003cstrong data-end=\"8180\" data-start=\"8163\"\u003esleep hygiene\u003c\/strong\u003e, \u003cstrong data-end=\"8195\" data-start=\"8182\"\u003ehydration\u003c\/strong\u003e, \u003cstrong data-end=\"8213\" data-start=\"8197\"\u003eelectrolytes\u003c\/strong\u003e, and \u003cstrong data-end=\"8230\" data-start=\"8219\"\u003eprotein\u003c\/strong\u003e during heavy training\/work.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8399\" data-start=\"8261\"\u003e\n\u003cp data-end=\"8399\" data-start=\"8263\"\u003e\u003cstrong data-end=\"8286\" data-start=\"8263\"\u003eWhen to avoid\/stop:\u003c\/strong\u003e Persistent \u003cstrong data-end=\"8310\" data-start=\"8298\"\u003einsomnia\u003c\/strong\u003e, \u003cstrong data-end=\"8331\" data-start=\"8312\"\u003etachyarrhythmia\u003c\/strong\u003e, \u003cstrong data-end=\"8351\" data-start=\"8333\"\u003emarked anxiety\u003c\/strong\u003e, or \u003cstrong data-end=\"8370\" data-start=\"8356\"\u003eBP \u0026gt;140\/90\u003c\/strong\u003e despite timing\/dose changes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"8404\" data-start=\"8401\"\u003e\n\u003ch3 data-end=\"8429\" data-start=\"8406\"\u003eSelected References\u003c\/h3\u003e\n\u003cul data-end=\"9224\" data-start=\"8431\"\u003e\n\u003cli data-end=\"8599\" data-start=\"8431\"\u003e\n\u003cp data-end=\"8599\" data-start=\"8433\"\u003e\u003cstrong data-end=\"8491\" data-start=\"8433\"\u003eNeuroscience \u0026amp; Behavioral Physiology; Human Physiology\u003c\/strong\u003e — Actoprotector concept, performance under heat\/sleep restriction; mitochondrial and antioxidant markers.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8754\" data-start=\"8600\"\u003e\n\u003cp data-end=\"8754\" data-start=\"8602\"\u003e\u003cstrong data-end=\"8649\" data-start=\"8602\"\u003eZhurnal Nevrologii i Psikhiatrii; CNS Drugs\u003c\/strong\u003e — Clinical studies in \u003cstrong data-end=\"8697\" data-start=\"8672\"\u003easthenia\/neurasthenia\u003c\/strong\u003e: anxiolysis with activation, clinician-rated outcomes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"8914\" data-start=\"8755\"\u003e\n\u003cp data-end=\"8914\" data-start=\"8757\"\u003e\u003cstrong data-end=\"8829\" data-start=\"8757\"\u003eBiochemistry (Moscow); Bulletin of Experimental Biology and Medicine\u003c\/strong\u003e — Up-regulation of \u003cstrong data-end=\"8860\" data-start=\"8849\"\u003eTH\/AADC\u003c\/strong\u003e, dopaminergic signaling, and mitochondrial enzymes.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9021\" data-start=\"8915\"\u003e\n\u003cp data-end=\"9021\" data-start=\"8917\"\u003e\u003cstrong data-end=\"8953\" data-start=\"8917\"\u003eInternational Immunopharmacology\u003c\/strong\u003e — \u003cstrong data-end=\"8977\" data-start=\"8956\"\u003eInterferon\/IgA\/NK\u003c\/strong\u003e changes (stress-linked immunomodulation).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9124\" data-start=\"9022\"\u003e\n\u003cp data-end=\"9124\" data-start=\"9024\"\u003e\u003cstrong data-end=\"9068\" data-start=\"9024\"\u003eAutonomic Neuroscience; Psychophysiology\u003c\/strong\u003e — Autonomic balance and vigilance metrics under load.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"9224\" data-start=\"9125\"\u003e\n\u003cp data-end=\"9224\" data-start=\"9127\"\u003e\u003cstrong data-end=\"9165\" data-start=\"9127\"\u003eDrug Testing \u0026amp; Analysis; WADA Code\u003c\/strong\u003e — Anti-doping status, detection windows, historical cases.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"8363\" data-end=\"8531\" class=\"\"\u003e \u003c\/p\u003e","brand":"Mijn winkel","offers":[{"title":"Default Title","offer_id":52684848922962,"sku":"10","price":30.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/bromantane_1g.png?v=1770834832","url":"https:\/\/sciencepeptideslab.com\/products\/bromantane-1g","provider":"Science Peptides Lab","version":"1.0","type":"link"}